The interplay between the Apicomplexan parasite Toxoplasma gondii and its host has been largely studied. However, molecular changes at the metabolic level in the host central nervous system and pathogenesis-associated metabolites during brain infection are largely unexplored. We used a global metabolomics strategy to identify differentially regulated metabolites and affected metabolic pathways in BALB/c mice during infection with T. gondii Pru strain at 7, 14 and 21 days post-infection (DPI). The non-targeted Liquid Chromatography-Mass Spectrometry (LC-MS) metabolomics analysis detected approximately 2,755 retention time-exact mass pairs, of which more than 60 had significantly differential profiles at different stages of infection. These include amino acids, organic acids, carbohydrates, fatty acids, and vitamins. The biological significance of these metabolites is discussed. Principal Component Analysis and Orthogonal Partial Least Square-Discriminant Analysis showed the metabolites' profile to change over time with the most significant changes occurring at 14 DPI. Correlated metabolic pathway imbalances were observed in carbohydrate metabolism, lipid metabolism, energetic metabolism and fatty acid oxidation. Eight metabolites correlated with the physical recovery from infection-caused illness were identified. These findings indicate that global metabolomics adopted in this study is a sensitive approach for detecting metabolic alterations in T. gondii-infected mice and generated a comparative metabolic profile of brain tissue distinguishing infected from non-infected host.
Introduction
The obligate intracellular Apicomplexan parasite Toxoplasma gondii is the etiological agent of toxoplasmosis, a common parasitic diseases that affects virtually all vertebrate species including humans [1] . Humans or animals become infected congenitally from an infected mother to the fetus, by ingestion of the parasite tissue cysts from undercooked or uncooked meat or by drinking water contaminated with oocysts shed in feline feces [2] . Usually, the clinical spectrum of the disease varies, depending on the host genetic background and genotype of the infecting strain, from asymptomatic infection in immune-competent people to severe illness in pregnant women and immunocompromised individuals [3] . Acute infection caused by the rapidly proliferating tachyzoites is efficiently controlled by the immune system [4] . Tachyzoites then transform into a slowly replicating stage (i.e. bradyzoites) enclosed in tissue cysts, and remain dormant within the central nervous system (CNS) and muscles [5] . In immuno-compromised individuals, latent infection can be reactivated and causes fatal consequences. For example, toxoplasmic encephalitis (TE) in AIDS patients is caused by the reactivation of quiescent infection in CNS when CD4 + cells become <200 per μl [6] .
Although infection in immune-competent people is generally benign, accumulating evidence indicated that T. gondii infection could modify the host's behavior and impair its learning capacity and memory [7] . Further evidence linked T. gondii infection to several mental disorders, such as schizophrenia, mood disorders and suicidal behavior [8] . The pathogenic mechanisms underlying T. gondii-induced behavioral and neuronal disorders remain largely unknown. During T. gondii infection, host undergoes many pathophysiological changes including metabolic, proteomic, histological changes, in order to maintain homeostasis and adapt to the conditions that is required for its survival under challenge caused by the infecting parasite. T. gondii can invade microglia, astrocytes, and neurons, with the majority of cysts are found in neurons [9, 10] . Microglia and astrocytes play important roles in intracerebral pathogen control by the production of antiparasitic and immunomodulatory effectors [11, 12] . But, the functional role of neurons is still largely unknown. In chronic infections, neuronal death and lesions are caused by the production of nitric oxide (NO) and inflammatory cytokines from immune cells [13] . Although much has been learned from such studies, they focus on individual molecules and failed to reveal the global effects of infection on the host. There is a need to elucidate the neuro-pathogenicity of this parasite and to identify infection-specific biomarkers that differentiate between acute and chronic toxoplasmosis.
In recent years, the effects of T. gondii infections on the host's brain have been studied with comprehensive methods, such as transcriptomics and proteomics to identify differentially expressed genes and proteins [14, 15] . Metabolic profiling (i.e. metabolomics) is an emerging field that involves identification and quantification of numerous low molecular weight compounds in various biological samples. This approach provides a powerful means for the measurement of the chemical phenotypes that are the net result of all activity on the transcriptome and proteome levels; therefore, it provides an integrated global profile of the status of test organism [16] [17] [18] . Previous studies have focused only on targeted metabolites, such as dopamine and homovanillic acid [19, 20] . However, toxoplasmosis is very likely associated with a complex array of chemical reactions and metabolites that stem from a diverse set of metabolic pathways associated with infection and inflammation. Therefore, we hypothesized that due to changes in brain function and metabolism caused by T. gondii infection, a characteristic pattern of metabolites would also be detectable.
The aim of this study was to determine whether metabolic profiling could be a reliable tool to detect alteration in the metabolome of brain of T. gondii-infected mice. For this purpose, BALB/c mice were experimentally infected with T. gondii Pru strain, and a LC-MS spectroscopy-based metabolomics approach was used to identify a characteristic metabolic 'biomarker pattern' in the brain of infected mice over the course of infection. The ability to discover significantly altered individual metabolites or metabolic pathways linked to T. gondii infection has been achieved. Physical recovery from acute toxoplasmosis has been correlated with biomarkers, which can be used as predictors of disease progression during T. gondii infection.
Material and Method Ethics statement
All animal procedures were approved by the Animal Ethics Committee of Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences (Permit No. LVRIAEC2014-002). All experiments were performed in strict compliance with requirements of the Animal Ethics Procedures and Guidelines of the People's Republic of China. We monitored infected mice for adverse health issues and efforts were made to minimize suffering. All infected mice were humanely euthanized by cervical dislocation under isoflurane inhalation anesthesia.
Mice
Female BALB/c mice were purchased from Lanzhou University, China. All mice had free access to food and water and were kept in a temperature-controlled room (22 ±0.5°C) on reverse 12/ 12 h light/dark cycle. Mice were acclimated for five to seven days before being used in the experiment. Prior to initiation of the work mice were weighed (weight>20g) to establish a baseline for detecting reduction in body weight caused by infection.
The parasite strain
Toxoplasma gondii type II Prugniuad (Pru) strain was maintained throughout the experiment via oral inoculation of cysts in mice. Cysts used in this study were isolated from brain tissues of infected BALB/c mice 40 days post-infection (DPI). Following anesthetizing animals, the brains of the infected mice were removed and homogenized in a tissue homogenizer under sterile conditions. Then, the number of cysts was counted and diluted to 100 cysts/ml in phosphate buffered saline solution (PBS).
Experimental infection and parasite detection in mice
Six-to eight-week-old BALB/c mice (n = 6 per group) were either left uninfected or inoculated orally with freshly prepared 10 cysts of T. gondii Pru parasites using a small gavage needle. Body weight was measured daily for 21 DPI, and all mice were checked daily for the development of clinical signs characteristics of toxoplasmosis. Six mice from each of infected and control groups were sacrificed at 7, 14 and 21 DPI. Samples from blood, liver, spleen, lung, small intestine and kidney were collected for the confirmation of the presence of T. gondii as previously described [21] . Briefly, genomic DNA was extracted from representative body tissue samples using TIANamp Genomic DNA kit (TianGen™, Beijing, China) according to the manufacturer's instructions. Specific PCR that targets 35-fold repeated B1 gene was applied to detect T. gondii infection in mice tissues using the specific primers (5 0 -AAC GGG CGA GTA GCA CCT GAG GAG-3 0 and 5 0 -TGG GTC TAC GTC GAT GGC ATG ACA AC-3 0 ). Positive control of DNA from parasites and negative controls (PBS) were included in each test. Also, pairs of adjacent 5-mm square sections from brain samples collected at different time points post infection were fixed in 10% neutral buffered formalin solution for 2 weeks, dehydrated in a graded series of ethanol, embedded in paraffin wax, and then cut into 5μm-thick serial sections on a microtome. They were then stained with hematoxylin and eosin [22] . Pathological changes were observed under optical microscope.
and stored at −80°C until processing. Nearly 100mg sample was homogenized in 500 μl of a solvent of acetonitrile-water (7:3), treated with ultrasonic wave for 15 min. The mixture was centrifuged at 12,000rpm for 15min, at 4°C. Supernatant (200 μl) was transferred to a new 1.5 ml polypropylene tube before liquid chromatography separation. The LC-MS system was run in a binary gradient solvent mode consisting of 0.1% (v/v) formic acid/water (solvent A) and 0.1% (v/v) formic/methanol (solvent B). The flow rate was 0.2 mL/min. A C18 column (Agilent Technologies, Santa, Clara, CA) (1.8 μm, 100×2.1 mm) was used for all subsequent analysis. The linear gradient was as follows: 5% B at 0 min, 5% B at 2 min, 95% B at 17 min, and 95% B at 19 min.
Sample analysis was carried out in both positive electrospray ionization (ESI+) and negative ion (ESI−) modes. The column temperature was 45°C and the injection volume was 5 μl. LC-MS data was acquired using an Agilent 1290 Infinity LC System coupled to an Agilent 6530 Accurate-Mass Quadrupole Time-of-Flight (Q-TOF) (LC-Q/TOF-MS). The mass scan range was 100-1000 m/z. For positive ion mode, the capillary and cone voltage were set at 4 kV and 35 kV, respectively. Nitrogen was used as the dry gas. The desolvation gas was set to 600 L/h at 350°C; the cone gas was set to 50 L/h and the source temperature was set to 100°C. For negative ion mode, the capillary and cone voltage were set at 3.5kV and 50 kV, respectively. The desolvation gas was set to 700 L/h at 300°C; the cone gas was set to 50 L/h and the source temperature was set to 100°C. The mass spectrometry was operated in V optics mode and the data acquisition rate was set to 0.03s, with interscan delay of 0.02s. To ensure accuracy and reproducibility LockSpray was used in all analyses and Leucine-enkephalin was selected as the lockmass.
LC-MS data processing and statistics
Agilent MassHunter Workstation QTOF Acquistition software (B.03.01) was used for data acquisition. LC-MS raw data files were converted into common format (.mzdata), which was followed by data processing through the XCMS toolbox (http://metlin.scripps.edu/xcms/) [23] . Peak picking, peak grouping and retention time correction were all involved in data pre-treatment, which were done through the XCMS software that was implemented with the freely available R statistical language (v 2.13.1).
The retention time (RT)-m/z data pairs were used to indentify ion intensities of those detected peaks. The consistent variables (ion intensity information) were obtained by filtering peaks with 80% missing values. In order to remove the offsets and adjust the importance of high and low abundance metabolites to an equal level, the data was preprocessed by both mean-centering and variance-scaling prior to multivariate analysis. Then, the resulting threedimensional matrix that includes assigned peak indices (retention time-m/z pairs), sample names and variables further went through the multivariate data analysis.
The resulting scaled datasets were imported into SIMCA-P+ 11.0 (Umetrics, Umea, Sweden) for processing using principal components analysis (PCA), PLS-discriminant analysis (PLS-DA) and orthogonal partial least-squares-discriminant analysis (OPLS-DA), which were carried out to visualize the maximal metabolic alterations between each group at all time points. Metabolites found to be highly similar or discriminatory were compared to investigate differential alteration at various time-points post infection. The differential metabolites were selected when the statistically significant threshold of variable influence on projection (VIP) values obtained from the OPLS-DA model was larger than 1.0. Meanwhile, the p values from a two-tailed Student's t-test on the normalized peak areas were less than 0.05 [24] . Log2 fold change (FC) based on metabolite abundance was used to show how these selected differential metabolites varied between groups. The positive value indicates the level of a specific metabolite is increased. Meanwhile, the LC-MS abundance data set was imported into MeV software for heatmap generation. Diagnostic model was constructed by the marker metabolites that were extracted from the combining VIP value, p value and fold change. The classification performance (specificity and sensitivity) was assessed by the area under the curve (AUC) of the receiver-operator characteristic (ROC) curves using SPSS software.
Metabolite Identification
Putative metabolites were first derived by searching the exact molecular mass data from redundant m/z peaks against the online HMDB (http://www.hmdb.ca/), METLIN (http://metlin. scripps.edu/) and KEGG (www.genome.jp/kegg/) databases. A specific metabolite was sieved out when a match with a difference between observed and theoretical mass was less than 10 ppm. Then the metabolite molecular formula of matched metabolites was further identified by the isotopic distribution measurement.
Results

Parasite infections in mice
Through the detection of T. gondii B1 gene, all infected mice were tested positive for T. gondii infection (data not shown). Mice infected by T. gondii Pru strain showed normal body weight, slight decline of feed consumption and slight signs of illness on day 7. However, physical condition of mice worsened over time and showed the typical clinical features of toxoplasmosis by 10 DPI, including anorexia, weight loss, edema and messy hair. More than half of the infected mice began to return to healthy status on day 14 post infection. Mice in the control group appeared normal and were tested negative for T. gondii infection during the whole experiment. Using hematoxylin and eosin (HE) staining, brain samples (7, 14 and 21 DPI) were examined for the severity and distribution of inflammation, tissue destruction, cell degeneration, and the numbers of cysts. Uninfected control mice did not show any histological changes. No significant pathologic changes were noted on 7 DPI. Mice in the infected group presented perivascular cuffing and glial nodule on 14 DPI, as shown in Fig 1A and 1B, respectively. More lesions occurred as infection progressed. On 21 DPI, the number of purkinje cells increased in the infected mice brains, which might be necessary for the survival of olivary neurons and cerebellar granule cells [25] . Tissue cysts were intact and found multifocally throughout many sections, which appeared in the proximity of glial foci, as shown in Fig 1D. Changes in brain metabolic profile with disease progression 
Global metabolic variations between infected and control mice
The differential metabolites associated with toxoplasmosis were identified according to VIP threshold (VIP >1) and the P-value of student's t-test after FDR correction. These identified metabolites include amino acid, peptide, carbohydrate, lipid, nucleotide, cofactors and vitamins, and are involved in a wide range of biological pathways. The statistically significant metabolites detected at different time points, their m/z values, log2 fold changes (FC) and descriptions are shown in Table 1 Fig 3A) , the levels of phosphatidylcholine (PC) (12:0), phosphatidylethanolamine (PE) (18:2), UDP-N-acetyl-D-galactosamine and aconitic acid were found to be higher in the infection group relative to healthy control group, whereas the levels of leukotriene D4 and inosine concentrations were found to be lower ( Fig 4A, S2A  Fig) . Among these metabolites, leukotriene D4 is an important inflammatory mediator, which is formed through a cascade metabolism pathway from arachidonic acid [26] . On day 14 (R ESI- (Fig 3B) , there were more altered metabolites. In the positive ion mode, levels of guanosine, guanine, hypoxanthine and inosine, important intermediates in purine metabolism, were shown to be more abundant in the infected mice group compared to those in the control group (Fig 4B) . Other metabolites that are involved in crucial metabolic pathways, such as propionyl-L-carnitine, acetylcarnitine and eicosapentaenoic acid, had similar changes. PC (18:0), PE (21:0), PE (P-16:0), PC (15:0)/PE (18:0), PC (15:1)/PE (18:1) showed significantly increased levels. Meanwhile, the levels of some other kind of phospholipids were found to be lower in the infection group than the control group, including phosphatidylinositol (PI) Under the ESI+ model, glutathione, which functions as an important antioxidant preventing damage to cellular components, was shown to be more abundant in the infection group than in the control group (Fig 4C) . Another key metabolite, glycerophosphocholine, which plays an important role in improving the brain function, has the same profile. Under the ESI-model, levels of glycerylphosphorylethanolamine, uridine monophosphate and uridine were higher in infected mice (S2C Fig). The rare amino acid pyroglutamic acid (a metabolite in the glutathione cycle) was shown to be less abundant in the infection group. Metabolites that have the similar profiles included citric acid and pantothenic acid. Phospholipids that are a major component of all cell membranes were found to be down-regulated at this period, including PE 
Differential expression of host brain metabolomes among T. gondii infected mice groups
To understand the metabolomic changes in the mice brain during different stages of T. gondii infection, a two-component OPLS-DA model was constructed to achieve a distinct separation between different infection groups ( Fig 5) . As shown in Table 2 , there were many significant alterations in the brain levels of several metabolites, especially between 14 DPI group and 7 DPI group (R ( Fig 5A) . In the positive ion mode, the levels of pantothenic Acid, propionyl-L-carnitine, 3-ketosphingosine, hypoxanthine and inosine were significantly higher in the brain on 14 DPI (Fig 6A) . Up-regulated metabolites in negative ion mode included N-Acetylleucine, FMN and ascorbic acid. Meanwhile in the same ion mode, metabolites that were significantly down-regulated included taurine, L-Aspartic acid, ascorbic acid, phosphocholine, γ-aminobutryic acid, ophosphorylethanolamine, dUTP, N-acetylsphingosine 1-phosphate, choline and acetyl-CoA. Most significantly altered phospholipids were up-regulated no matter in positive ion mode or negative ion mode (Fig 6A, S3A Fig) . Only the levels of PC (12:0) and PI (22:2) (log2 fold change:-1.12, -0.74, respectively) were decreased. These results showed that phospholipids anabolism was active during the transitional phase from physical illness to recovery. Brain samples from 21 DPI group and 14 DPI group showed a very high segregation (R (Fig 5C) , in which Q 2 were less than 0.4 in both ion modes. The number of significantly changed metabolites was very small between 21 DPI group and 14 DPI group. Glycerophosphocholine was the highest abundance metabolite (log2 fold change = 1.15) and pantothenic acid was the lowest (log2 fold change = -1.06) (Fig 6C) . Comparisons between 21 DPI group and 7 DPI group showed that oxoglutaric acid, also called α-ketoglutarate (an intermediate in the Krebs cycle), was shown to be more abundant (log2 fold change = 1.87) (S3B Fig). The level of carnosine, choline and citric acid were slightly decreased. Glycerylphosphorylethanolamine, known to improve in vivo the learning and memory processes, was up-regulated.
Identification of potential biomarkers
Infected mice began to restore their health on day 14, showing an increased appetite and enhanced mental state. We then investigated metabolites that have the potential to be used as biomarkers for the prediction of physical recovery from acute T. gondii infection. To select potential marker metabolites, differential metabolites identified on the 14 day were subjected to ROC analysis. The differentiation performance (specificity and sensitivity) was assessed by the area under the curve (AUC>0.85) and eight significantly differential metabolites were selected as potential biomarkers, as shown in Table 3 . Some marker metabolites are involved in purine metabolism as illustrated in Fig 7 .
Discussion
In the present study, LC-MS-based metabolomic analysis technology was used to identify characteristics of the metabolite profiles of mice infected with T. gondii and to discover biomarkers that discriminate T. gondii-infected from non-infected controls. LC-MS based metabolomic profiling studies have become an increasingly powerful tool to analyze the interaction between parasites and their hosts, such as malaria caused by another apicomplexan protozoan Plasmodium falciparum [27, 28] and human African trypanosomiasis (HAT) [29] . In these studies, marked alterations in host's metabolic profiles were detected and some perturbed metabolites were identified as biomarkers with a potential diagnostic value. Likewise, in our study we have profiled the dynamic metabolic changes in mice brain infected by T. gondii Pru strain over the course of 21 DPI. We found metabolic shifts between T. gondii infected and non-infected mice as well as between T. gondii infected mice at different time points post infection. Infected mice began to exhibit clinical signs of toxoplasmosis at 7 DPI. As the disease progresses, mice exhibited typical symptoms of acute infection around 11 DPI. Although some mice also become more dispirited, less energetic, and exhibited weight loss and reduced physical activity at 14 DPI, they appeared to regain health. Most infected mice regain health at 21 DPI, which correlated with increased appetite and improved physical activity. Pathological studies demonstrated significant structural changes occurred by 21 DPI, including inflammatory cell infiltration and the presence of parasite cysts, which are correlated with the changes of brain metabolism.
Brain samples were collected at different time points (7, 14 and 21 DPI) and analyzed to profile the parasite-induced metabolite changes related to the brain injury. OPLS-DA as a supervised pattern recognition process was necessary to maximize the variation associated with the mice health status. Each data point represents one brain sample, and the distance between points in the score plot is an indication of the similarity between samples. The score plots showed that all the infected groups could be easily distinguished from the corresponding control groups and the infected groups at different time points could also be clearly separated.
Both T. gondii infected and uninfected mice brains were analyzed to determine the parasiteinduced alterations to normal brain metabolism. Mice at the early infection stage (7 DPI) showed a slight shift in metabolism, which was marked by an increase of UDP-N-acetyl-Dgalactosamine (ESI-) and a decrease of leukotriene D4 (ESI+). Most of the detected metabolites showed peak or minimum abundance at 14 DPI, a period close to the acute infection [30] . The metabolome closely reflects the activities of the brain at the functional level and the metabolites that fluctuated with disease progression are indicative of the major metabolic processes that are closely related to the regulation of T. gondii infection. For example, cytidine, a decomposition product of cytidine monophosphate (CMP), was down-regulated along with the L-aspartic acid, which is an important building block of the de novo pyrimidine biosynthetic pathway in T. gondii. Arginine follows a similar profile. Previous studies showed arginine starvation could trigger differentiation of tachyzoites to bradyzoites, the slowly replicating stage contained within stable cyst-like structures [31] . These findings demonstrate that alteration of host metabolites (e.g. arginine) can modulate T. gondii phenotype (tachyzoite-bradyzoite) switching, an integral part of the infection process, which enables the parasite to hide inside host cells. It is well established that the glucose is the primary energy source for brain. However, under starvation or fasting conditions, fatty acids could substitute glucose as an alternative substrate for brain energy metabolism. With regard to dietary intake by infected mice and energy demands for survival, the metabolite profiles of carnitine and lipid species in the brain is very worthy of attention. Significantly altered carnitines and phospholipids indicate variation of fatty acids oxidation metabolism and phospholipids metabolism, respectively. For example, acetyl-carnitine, an acetyl derivative of L-carnitine, was found to be more abundant in the infected mice group, which is consistent with others [32] . Acetyl-carnitine is involved in fatty acids oxidation metabolism, in which its acetyl groups are mostly incorporated into saturated fatty acid [33] . Apart from its role in reducing oxidation of glucose, acetyl-carnitine also takes part in many neuro-protective roles [34] [35] [36] . Propionyl-L-carnitine, playing a significant role in fatty acid oxidation and energy expenditure, were also shown to be more abundant at the same time [37] . Phospholipid is a major component of all cell membranes as it forms the phospholipid bilayer. Variations of PC, PI, PA and PE levels were observed between infection mice and the healthy ones ( Table 1 ). The precursors of membrane phospholipids, phosphocholine and phosphoethanolamine, were down-regulated due to the presence of T. gondii infection. Phosphocholine is an intermediate in the synthesis of phosphatidylcholine, during which ATP and choline are converted into ADP and phosphocholine via catalysis by choline kinase. Phosphatidylethanolamine, synthesized by phosphoethanolamine, is found in all living cells, especially in nervous tissues. The decline of these two metabolites might be bound up with reduced food intake.
Mentally, infected mice exhibited lethargy and energetic dispirited, which might link with the metabolites variations. For instance, taurine is the second most abundant amino acid in the CNS, which showed significantly decreased levels at this period. Taurine functions as a key regulator of neuronal activity, neuromodulator and osmoregulator [38] . Moreover, it takes part in the development and survival of neural cells [39] . Gama-Aminobutyric acid (GABA), as the main inhibitory neurotransmitter in the CNS, also showed similar profile, which is found to function in reducing neuronal excitability [40] .
The physical condition of infected mice becomes improved by 21DPI. The number of metabolites with statistically significant variations in abundance decreased at this period. Metabolites that were involved in the restoration of physical fitness of mice were elevated. For example, glutathione, as an important antioxidant, was up-regulated in the infected mice. Glutathione assists in the defense against reactive oxygen species generated during oxidative metabolism and also plays an important role in DNA repair and protein synthesis [41] [42] [43] .
Direct comparisons of metabolite levels between day 14 and day 7 PI showed the most dramatically changed metabolites as shown in Table 2 . Pantothenic acid, also known as vitamin B5, was significantly elevated with the log2 fold change of 1.78. Pantothenic acid is required for the synthesis of coenzyme A (CoA) that is involved in metabolism of fats, carbohydrates, and amino acids [44] . Acetyl coenzyme A (Acetyl-CoA) derived from CoA under acylation reaction was down-regulated. This metabolite participates in many essential metabolic pathways, such as citric acid cycle, glycolysis and fatty acid metabolism. Acetyl-CoA is also involved in the biosynthesis of the neurotransmitter acetylcholine. Choline and phosphocholine are other two metabolites that showed lower abundance, which are involved in the synthesis of acetylcholine. The deficiency of these metabolites might be directly bound up with abnormal physical activities. Oxoglutaric acid, also called α-ketoglutaric acid was the highest abundance metabolite when comparison was made between day 21 and day 7 PI. Oxoglutaric acid is an important intermediate in the tricarboxylic acid cycle and is involved in the synthesis of glutamine. The number of significantly changed metabolites between 21 and 14 DPI is small, which might account for health recovery at the metabolism level.
On day 14 PI, although demonstrating obvious pathogenic signs, more than half infected mice had already begun to recover. Marker metabolites that were responsible for the separation of the day 14 infected mice group from the control group were summarized in Table 3 . The levels of all these metabolites were found to be statistically different (p < 0.05) and marker metabolites selected in this period were involved in many crucial metabolic pathways. For example, guanosine, guanine, hypoxanthine and inosine, intermediates in the purine salvage pathway, reached their peak abundance at 14 DPI. For the host, purine salvage pathway is the main way for purine synthesis in the brain. Purine salvage pathway is considered more energy efficient and integral to the cause or treatment of a number of human diseases of purine metabolism [45] . Because T. gondii is not able to synthesize purines de novo, it is more reliant on the purine metabolic enzymes and intermediates in the purine salvage pathway to ensure growth [46] . As the parasite's sole source of purine bases, this salvage pathway is also essential for cyst growth and has been considered a potential target of new anti T. gondii drugs [47] .
In conclusion, metabolomic analysis yielded a clear separation between non-infected and T. gondii-infected mice groups, indicating a substantial imprint from the infection on the metabolism of mice during the progression of the disease. In a longitudinal study, the strongest separation occurred around 14 DPI. Altered metabolomic pathways included changes in carbohydrate metabolism, lipid metabolism, energetic metabolism and fatty acid oxidation. Perturbed metabolites and pathways detected in this study may provide valuable information for discovery of new targets for novel therapeutic and diagnostic applications. Although biomarker discovery using experimental infections has the benefit of documenting when the biomarker detects the infection, validation of the use of metabolomics to detect infection under field conditions will need to be done to ultimately demonstrate its utility.
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